vaccine

Race For Vaccine Tests Limits Of Drug Innovation

March 31, 2020 6:26 pm

From medical workers struggling to care for the rising tide of COVID-19 patients to the billions of people told to stay home to slow the pandemic, everyone is waiting for one thing: a vaccine.

There is no known treatment for the new coronavirus that emerged in China late last year and has since proliferated across the planet, infecting more than half a million people and claiming more than 30,000 lives.

In mid-January, researchers from China published the genetic sequence of the virus, firing the starting gun for dozens of research labs across the world in the race to find effective …

Africa: The Search For An Effective HIV Vaccine Continues

February 17, 2020 1:17 pm

An HIV vaccine trial that started in 2016 in South Africa was halted in February 2020. The study sponsors made the call after interim results showed that the vaccine, known as HVTN 702, did not prevent HIV. This result was disappointing, but the search for an effective HIV vaccine continues. Anatoli Kamali speaks to The Conversation Africa’s Ina Skosana about other developments in the field.

Why do we need an HIV vaccine?

HIV remains a dangerous pandemic. The number of new infections remains high – about 1.7 million new cases every year. Young people, particularly young women, account for

…

Second Ebola Vaccine To Be Used In DR Congo Next Month

October 13, 2019 2:40 pm

Doctors will use a second Ebola vaccine from November in three eastern provinces in the Democratic Republic of Congo to fight the deadly virus, medical officials said Sunday.

“It’s time to use the new Ad26-ZEBOV-GP vaccine, manufactured by Johnson & Johnson’s Belgian subsidiary,” said Dr. Jean-Jacques Muyembe, who leads the national anti-Ebola operation in the DRC.

It will arrive in the eastern city of Goma, in North Kivu province, on October 18 and be used from the beginning of next month, he added.

DRC’s latest Ebola epidemic, which began in August 2018, has killed 2,144 people, making it the second …